Literature DB >> 3873499

Separate control of B lymphocyte early activation and proliferation in response to anti-IgM antibodies.

A L DeFranco, E S Raveche, W E Paul.   

Abstract

Resting B cells enter and progress through the G1 phase of the cell cycle in response to low concentrations (1 to 5 micrograms/ml) of anti-IgM antibodies. Commitment to enter S phase requires the presence of a fivefold to 50-fold higher concentration of anti-IgM. These and other results strongly suggest that two separately controlled events are involved in B cell activation. The current studies demonstrate that B cells incubated with high concentrations of anti-IgM from the initiation of culture become independent of additional anti-IgM approximately 10 hr before entry into S phase. We have designated this anti-IgM independent portion of the G1 phase of the cell cycle as G1 beta, whereas the earlier phase is referred to as G1 alpha. Furthermore, low concentrations of anti-IgM are sufficient for progress through early portions of G1 alpha, but high concentrations are required for the last 4 to 8 hr (G1 alpha') if the cells are to go through the rest of the cell cycle. Removal of anti-IgM at any time during G1 alpha causes prompt cessation of the size enlargement that accompanies progress through G1. Such cells retain their size and their relative place in G1 for periods of at least 17 hr and recommence movement through G1 alpha phase when anti-IgM is readded. Thus, B cells may exist in states of partial activation and must possess a mechanism to integrate the amount of stimulatory signal they have received; they enter a commitment period for S phase only when that signal passes some threshold value.

Mesh:

Substances:

Year:  1985        PMID: 3873499

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  25 in total

Review 1.  Cell cycle control mechanisms in B-1 and B-2 lymphoid subsets.

Authors:  Michael J Piatelli; Debra Tanguay; Thomas L Rothstein; Thomas C Chiles
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

2.  Characterization of two monoclonal antibodies (UCL4D12 and UCL3D3) that discriminate between human mantle zone and marginal zone B cells.

Authors:  J Smith-Ravin; J Spencer; P C Beverley; P G Isaacson
Journal:  Clin Exp Immunol       Date:  1990-10       Impact factor: 4.330

Review 3.  Membrane Ig-mediated triggering of B cell tolerance and B cell clonal expansion: implications for rheumatoid factor production in rheumatoid synovitis.

Authors:  P K Mongini; S M Rudich
Journal:  Springer Semin Immunopathol       Date:  1989

4.  Ligand-induced desensitization of B-cell membrane immunoglobulin-mediated Ca2+ mobilization and protein kinase C translocation.

Authors:  J Cambier; Z Z Chen; J Pasternak; J Ransom; V Sandoval; H Pickles
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

5.  Arp2/3 complex-driven spatial patterning of the BCR enhances immune synapse formation, BCR signaling and B cell activation.

Authors:  Madison Bolger-Munro; Kate Choi; Joshua M Scurll; Libin Abraham; Rhys S Chappell; Duke Sheen; May Dang-Lawson; Xufeng Wu; John J Priatel; Daniel Coombs; John A Hammer; Michael R Gold
Journal:  Elife       Date:  2019-06-03       Impact factor: 8.140

6.  Antigen-independent regulation of cytoplasmic calcium in B cells with a 12-kDa B-cell growth factor and anti-CD19.

Authors:  J A Ledbetter; P S Rabinovitch; C H June; C W Song; E A Clark; F M Uckun
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

7.  Mitogenic response of murine B lymphocytes to Salmonella typhimurium lipopolysaccharide requires protein kinase C-dependent late tyrosine phosphorylations.

Authors:  A Mey; J P Revillard
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

8.  Phorbol myristate acetate inhibits anti-IgM-mediated signaling in resting B cells.

Authors:  J Mizuguchi; M A Beaven; J H Li; W E Paul
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

9.  Activation of human B cells mediated through two distinct cell surface differentiation antigens, Bp35 and Bp50.

Authors:  E A Clark; J A Ledbetter
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

Review 10.  Studies of surface immunoglobulin-dependent B cell activation.

Authors:  J G Monroe; V L Seyfert
Journal:  Immunol Res       Date:  1988       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.